Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01230593 · ClinicalTrials.gov registry record · NA
Chalazion Conservative Treatment Trial
A NA study of Chalazion Unspecified Eye, Unspecified Eyelid and Chalazion Left Eye, Unspecified Eyelid, sponsored by McMaster University.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 3
- Study locations
NCT01230593 is a NA study of Chalazion Unspecified Eye, Unspecified Eyelid and Chalazion Left Eye, Unspecified Eyelid that has completed, run by McMaster University. The registered enrollment target is 150 participants. The trial reports 3 study locations across 2 states.
The verdict
NCT01230593, a NA study of Chalazion Unspecified Eye, Unspecified Eyelid and Chalazion Left Eye, Unspecified Eyelid, has completed, sponsored by McMaster University.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 3
- Study locations
Study Summary
An eyelid stye, or chalazion, is the most common eyelid ailment, and is caused by the blockage of one of the oil secreting glands of the eyelid (meibomian glands). This leads to a typically painful, swollen, and red eyelid bump that lasts from days to weeks and months. The chalazion may cause tearing, pressure on the cornea, and irritation, all of which contribute to its morbidity. There are many anecdotal first line treatments for this condition, including warm compresses to the eyelid, topical antibiotics, topical steroids, topical combination antibiotic/steroid, and oral antibiotics. There have been no clinical trials to compare the efficacy of any of these conservative treatments. We wish to determine the most effective conservative medical treatment for chalazia.
Conditions Studied
Interventions
- DRUG Hot Compress plus Tobramycin Drops and Ointment
- DRUG Hot compress plus Tobramycin/Dexamethasone Drops and Ointment
- OTHER Hot Compresses
Study Locations (3)
New York
- Elmhurst Hospital Center - Elmhurst
- Icahn School of Medicine at Mount Sinai - New York
Ontario
- St. Joseph's Hospital Eye Clinic - Stoney Creek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2010-11 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01230593
The ClinicalTrials.gov registry entry for NCT01230593 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is McMaster University, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Chalazion Unspecified Eye, Unspecified Eyelid appearing as the primary indexed condition, and to 3 interventions - of which Hot Compress plus Tobramycin Drops and Ointment is the first listed.
NCT01230593 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, Ontario.
Frequently Asked Questions
What is clinical trial NCT01230593 about?
NCT01230593 is a clinical study titled "Chalazion Conservative Treatment Trial". An eyelid stye, or chalazion, is the most common eyelid ailment, and is caused by the blockage of one of the oil secreting glands of the eyelid (meibomian glands). This leads to a typically painful, swollen, and red eyelid bump that lasts from days to weeks and months. The chalazion may cause tearin...
What is the current status of trial NCT01230593?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2010-11. Estimated completion is 2016-03.
What conditions does trial NCT01230593 study?
This clinical trial studies the following conditions: Chalazion Unspecified Eye, Unspecified Eyelid, Chalazion Left Eye, Unspecified Eyelid, Chalazion Right Eye, Unspecified Eyelid, Chalazion Both Eyes.
What interventions are being tested in trial NCT01230593?
The interventions under investigation include: Hot Compress plus Tobramycin Drops and Ointment (DRUG), Hot compress plus Tobramycin/Dexamethasone Drops and Ointment (DRUG), Hot Compresses (OTHER).
Who is sponsoring clinical trial NCT01230593?
This trial is sponsored by McMaster University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01230593 being conducted?
This trial has 3 study locations across New York, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Chalazion Unspecified Eye, Unspecified Eyelid
All registered trials for this condition
Chalazion Left Eye, Unspecified Eyelid
All registered trials for this condition
New York
All trials with a study site in New York
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.